You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股異動 | 輝瑞漲3.5% 美國CDC薦5-11歲兒童接種輝瑞兒童版新冠疫苗加強針
格隆匯 05-20 22:28
格隆匯5月20日丨輝瑞(PFE.US)漲3.5%,報52.43美元,總市值2941億美元。美國疾病控制與預防中心(CDC)的獨立疫苗專家團隊推薦5至11歲兒童接種輝瑞的新冠疫苗兒童版加強針。據瞭解,目前,隨着美國各地的感染病例不斷增加,此前已接種的兩針疫苗的免疫效力已下降。據瞭解,自去年11月批准為5-11歲兒童接種初次兩針疫苗以來,美國已經為這一年齡組接種了超過1800萬劑輝瑞疫苗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account